Molecular Tumor Board and Precision Oncology Fundamentals

As precision medicine transforms oncology, understanding how to analyze and act on genomic data is essential for modern healthcare professionals. This text-only course guides you through the core concepts of the Molecular Tumor Board (MTB) process, from DNA sequencing results to clinical decision-making. You will transition from understanding basic cancer biology to confidently interpreting complex genomic reports. By studying structured clinical cases and written walkthroughs, you will learn how multi-disciplinary teams select targeted therapies based on a patient's unique genomic profile. What you'll learn: • Understand the role and workflow of a multidisciplinary Molecular Tumor Board • Interpret genomic variants using standard clinical classification guidelines • Identify actionable mutations, resistance mechanisms, and targetable pathways • Evaluate clinical trial options and targeted therapies based on genomic reports • Analyze real-world clinical scenarios through detailed written case studies • Apply modern bioinformatics concepts to personalized cancer care decisions. The course begins with foundational concepts in cancer genomics and next-generation sequencing, before moving into variant interpretation frameworks and clinical decision-making strategies. Designed for medical students, oncology trainees, researchers, and healthcare professionals new to genomic medicine, with no prior molecular pathology experience required. Start reading today to master the essentials of precision oncology and clinical variant interpretation.